chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Superficial perivascular dermatitis on all parts of the body and face due to fixed drug (vaccine) eruption; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 15:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, shellfish allergy and COVID-19 respiratory infection. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); both started on unknown dates and for unspecified indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 19Apr2021 at 00:00, the patient experienced superficial perivascular dermatitis on all parts of the body and face due to fixed drug (vaccine) eruption. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event which included treatment with prednisone (MANUFACTURE UNKNOWN) started on unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of event superficial perivascular dermatitis was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Excessive shivering, extreme feeling of cold, body and joint ache, weakness, dizziness, nausea, headache. Took ibuprofen.
My throat felt a little scratchy on Saturday and I didn't think anything of it. I felt a bit run down. Sunday night into Monday, I had a really bad sore throat and a headache. I took a migraine pill but the sore throat continued. I tested the next day. Today when I went to my mother's home, I felt very sick and very weak. I cannot physically do what I needed to do. I started the PAXLOVID last night. I never have had any fever. I sweat profusely during the night after I took the medicine. I can feel the medication drying me up. I'm still stuffy and can feel it in my head. I have the cough and tiredness and that's about it. I wanted the antiviral because the cough got worst. I do not feel I have recovered yet.
patient received the COVID vaccine at 10:30 am today and developed a rash a few hours later at school. Rash images were sent to PCP and appear to be hives. No other symptoms at this time related to the vaccine
Pain in arm around injection site for 36 hours post-injection; joint pain for 36 hours post-injection.  Rash below injection site developed 8 days post injection.  Rash was red, blotchy, itchy and painful, gradually resolved over 4 days.  Also pain in latissimus dorsi on the left side.
administered the hpv gardisal 9 vaccine on a 3 year old. spoke to parent the following day parent reports no side effects no changes in the child.
Rotavirus was given as an intramuscular injection, and it is supposed to be given orally.  The amount of immunization injected exceeded 1 ml/one site.
The Headache/Pressure is there in the morning, and I feel fatigued, like I really didn't get any rest in the night.,  And  the headache/pressure stays with me all day., But I don't believe it wakes me in the night, I did developed blurry vision, but only in one eye (right)., I went to Eye doctor, and they said it appeared a cataract had developed since the last visit. but the blurry vision has somewhat improved with reduction of the blood pressure., as far a dizziness., I would not feel comfortable going out and flying a plane since the covid vaccine shot, so I'd say I am a little unstable on my feet right now.....
Patient was accidently given a Moderna dose that was approx 1-2 hours past the expiration date of being at room tempature.
Hx of anxiety with imms but no hx of syncope, has never had any jerking or an anxiety attack before, 15 seconds after imm pt pale and asks if she can sit here for a few minutes, RN asks if feeling lightheaded-no response, then lowers her head and draws up bil arms and begins rythmic jerking of bil arms and torso, RN calls code blue and second RN responds right away, pt safely lowered to the ground by two RN's-feet elevated, 911 called and VS obtained 110/60 98 16 98% on RA,  after 20 seconds jerking self resolves, pt opens her eyes and immediately asks what happened, pupils remain  dilated, she remember events up to asking if she can sit here for a minute, denies any tightness to chest or throat, denies difficulty breathing, no wheezing or rash noted by RN, pt laid on ground for about 10 minutes and was then escorted with 2 person assist to the lobby to wait for EMS to arrive, pt remained pale and clammy and light headed, 1305- pt father notified of incident 1320-RN gives report to EMS in lobby, pt still laying on ground with feet elevated but laughing and talking to her friends, BP now 114/64 and color is improved, RN advised her to follow up with her PCP 1330-pt sitting up in chair and BP 110/60
Pt is a 81 yo female with a history of CVA, DM2, HFpEF, HTN, GERD, HLD, Afib (on apixiban), COPD baseline 2L NC. She is also s/p Pfizer vaccination: dose 1 on 1/23/21 and dose 2 on 2/13/21. She presented to the ED on 9/13 with altered mental status, hypoxia and increased oxygen requirements. Patient was found to be COVID positive despite getting the Pfizer vaccine in January and February of this year. In the ED patient found to have AKI on ESRD, Potassium 6.0, Creatinine 6.09 and BUN 166. She was treated with insulin and dextrose, nephrology was consulted and placed orders for CRRT. Patient was found to have a lactic acidosis (lactate 6.3) and was intubated due to hypoxia and increased work of breathing (continued)  Levo also initiated in the ED after patient received 1L IVF. Started on dexamethasone and remdesivir on 9/13.  Patient went into Afib with RVR and was put on an amiodarone gtt in addition to heparin gtt. Lower respiratory cx grew Proteus and MSSA. Patient was also found to be COVID+. Shock continued to worsen between 9/14 to 9/16 and the patient required Phenylephrine, Giapreza, and Vasopressin in order to maintain her blood pressures with MAP > 60. She required CRRT for AKI with hypotension. Echo showed EF of 70% with elevated RVSP, but fluid could not be pulled consistently with CRRT given her blood pressures. After maximum rates of 3 vasopressors did not achieve normotension, she was transitioned to DNRCC. Time of Death was 2119 on 9/16.
Expired vaccine Injected to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine Injected to patient) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine Injected to patient). On 14-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine Injected to patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported by the reporter. No treatment drugs were reported  The reporter stated the patient was vaccinated with a dose from a punctured vial of Moderna COVID-19 Vaccine that had been sitting at room temperature since 11-May-2021.   This case was linked to MOD-2021-220907 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received and contains no new information
Swelling and redness at injection site. Size of swollen area 4-5 inches in diameter. Swelling area was 1/2" in height. Area was hot to the touch. Muscle soreness. Headache. Fever. Flu-like symptoms lasting  seven to ten days. Consulted primary care physician on 06/26/2018. Was advised to NOT get second vaccination. Injection site still shows some redness and slight swelling in an area approx 1/2 " in diameter.
Inconsistent menstrual cycle started after receiving second Moderna COVID 19 vaccine. Have had multiple menstrual cycles in one month. Menstrual bleed has been heavier. Cramping has been more painful. Also experienced migraines during menstrual cycles. Menstrual cycles have been inconsistent from September 2021 through January 2022.
Severe pain/pain was located in the back, abdomen, right kidney/back area; Severe pain/pain was located in the back, abdomen, right kidney/back area; Severe pain/pain was located in the back, abdomen, right kidney/back area; This is a spontaneous report from a contactable consumer (Patient wife).   A 75-years-old male patient received first dose of bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3248), via an unspecified route of administration, administered in arm left on 09Feb2021 12:10 (at the age of 75-years-old) as dose 1, single for covid-19 immunization. Vaccination facility: Hospital. Vaccine was Administered at Facility. Medical history included ongoing blood thinner, Heart/heart condition and aneurysm (He has an old aneurysm that is still there, this was about 12 years ago). Concomitant medication included rivaroxaban (XARELTO) for blood thinner, iron (MANUFACTURER UNKNOWN) for an unspecified indication, metoprolol succinate (MANUFACTURER UNKNOWN) for heart, all from an unspecified start date and ongoing. Prior vaccinations no other medication received within 4 weeks. It was reported that Caller on the line calling about her husband. He received the first shot, the first shot of the COVID 19 Vaccine and had a possible side effect. She mentioned her husband was on a blood thinner. He did not know prior to getting the vaccine he should have notified the person administering he was on a blood thinner. Did not know until after looked at paper work. Caller explained the patient was in severe pain. She was calling to see if this severe pain was possibly related to the vaccine. She also added, patient has a heart condition. He has an old aneurysm that was still there. Caller explained the severe pain started 5 AM this morning. As of now the pain was almost gone. The pain was located in the back, abdomen, right kidney/back area. Caller reiterated she was calling about the blood thinner because patient did not know should have notified the ones administering he was on a blood thinner. Caller stated she was debating on taking her husband to the ER, but would have to go 100 miles and does not want to do that. She stated if the severe pain continues then they would have to go to the Hospital. She added, with the aneurysm it could break and something want to be careful with. The adverse events did not require a visit to emergency room and Physician's Office. The outcome for the events was reported as resolving.   Follow-up attempts completed. No further information expected.
Upon receiving first dose, felt immediate burning pain radiating down left arm, affecting bicep and forearm.; loss of strength on left side to this date; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: FC3181) as dose 1, single for covid-19 immunisation. Relevant medical history included: "triple bypass", start date: 29Jan2005 (unspecified if ongoing), notes: triple bypass. Concomitant medication(s) included: METOPROLOL SUCCINATE; ROSUVASTATIN. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "Upon receiving first dose, felt immediate burning pain radiating down left arm, affecting bicep and forearm."; ASTHENIA (non-serious), outcome "not recovered", described as "loss of strength on left side to this date". The events "upon receiving first dose, felt immediate burning pain radiating down left arm, affecting bicep and forearm." and "loss of strength on left side to this date" were evaluated at the physician office visit.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Upon receiving first dose, felt immediate burning pain radiating down left arm, affecting bicep and forearm. Have burning pain and loss of strength on left side to this date. Upon receiving second dose pain radiating down full left side of body. Loss of Equilibrium, muscle loss on left arm and leg, burning aching pain in both arm and leg. Walk with a limp every day, very difficult to lift left leg more then a couple inches. Having irregular heartbeat. shortness of breath, gasping for air. Have to get up very slowly when sitting or loose balance. Never had an issue prior to getting Covid19 shot, patient health was in good order. Now life is falling apart. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Patient reports pain in little finger and 4th finger with some joint pain at elbow.  He feels it might be ulnar nerve inflammation. He wanted it reported however.
Information has been received from a physician concerning a female in her early 20's who sometime in mid November was vaccinated with her first dose of HPV Vaccine. It was reported that within 24 hours the patient experienced numbness in one of her legs and in her arm. The physician stated the patient still had numbness and that it had been over a week now and it had not subsided. The patient sought unspecified medical attention. Additional information has been requested.
Stinging & burning Deep bone pain. Duration approx. 7-8 hours Resolved without treatment
Patient received second dose of Pfizer vaccine and after about 20 minutes of receiving dose began to feel dizzy and vomit.  Heart rate slightly elevated.   Patient was taken to emergency room for further evaluation.
The pt received the Td vaccine IM in the right deltoid muscle on 4/10/00. The pt experienced a hard lump and soreness since that time.
Developed headache on the following day from vaccination with numbness present on bilateral face, that is still present 5 days later.  Also reports cough and chest tightness
Period immediately following vaccination had more blood clots; period immediately following vaccination had more cramps; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Period immediately following vaccination had more blood clots) and DYSMENORRHOEA (period immediately following vaccination had more cramps) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014F21A, 004M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Nov-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (Period immediately following vaccination had more blood clots) and DYSMENORRHOEA (period immediately following vaccination had more cramps). At the time of the report, HEAVY MENSTRUAL BLEEDING (Period immediately following vaccination had more blood clots) and DYSMENORRHOEA (period immediately following vaccination had more cramps) outcome was unknown.            CC: This is a spontaneous case concerning a 42-year-old female patient with no reported medical history, who experienced the non-serious  unexpected events Heavy menstrual bleeding and dysmenorrea . The events on the same day after receiving the third   dose of mRNA-1273.  The benefit-risk relationship of mRNA-1273 is not affected by this report.  No Concomitant medication was reported.    No treatment medications were reported.   This case was linked to MOD-2021-405203, MOD-2021-405201 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 42-year-old female patient with no reported medical history, who experienced the non-serious  unexpected events Heavy menstrual bleeding and dysmenorrea . The events on the same day after receiving the third   dose of mRNA-1273.  The benefit-risk relationship of mRNA-1273 is not affected by this report.
This case was reported by a healthcare professional and described the occurrence of pneumonia in a child subject of unspecified age and gender who was vaccinated with HAVRIX (GlaxoSmithKline). There were no concurrent medications. On an unspecified date the subject received a dose of HAVRIX. At an unspecified time after vaccination with HAVRIX, the subject was taken to the hospital where a diagnosis of pneumonia was reported. It was suggested that the child was admitted to the hospital. At the time of reporting the outcome of the event was not specified.
Approximately noon 2 days after vaccination 2/26/2021 patient began to experience weakness, vomiting, dry heaving, abdominal pain and muscle aches. At some point during the night he wound up on the floor and eventually yelled for help. He was unable to get up by himself and was down there for an unknown amount of time. His spouse believes a few hours. He then continued the same symptoms and wife gave him crackers, sprite and fluids. He slept Saturday night in his recliner, He was still unwell Sunday morning so she called an ambulance who took him to ER. He was then sent to another hospital.  Initially thought he had kidney and liver failure as well as heart attack but she states the muscle damage is what cause the labs to look similar to a heart attack and his kidneys and liver were trying to expel toxins/waste from muscle damage and he was very dehydrated. His liver and kidneys recovered  in about 2 or 3 days and he received IVF and  spent 7 days at the hospital and is still in Rehab recovering.
Moderna rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Moderna rash) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Moderna rash). The patient was treated with FLUOCINONIDE (topical) at a dose of 5 percent; CLOBETASOL PROPIONATE for Rash pruritic, at a dose of 5 percent; HYDROXYZINE HCL for Sleep disorder, at a dose of 10 mg three times a day; CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at an unspecified dose and frequency; CLOBETASOL for Itchy scalp, at a dose of 5 percent; TRIAMCINOLONE ACETONIDE at an unspecified dose and frequency and PREDNISONE at a dose of 20 mg. At the time of the report, VACCINATION SITE RASH (Moderna rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.   This case was linked to MOD-2021-265796 (Patient Link).   Reporter did not allow further contact
Vaccine administrator inadvertently gave Pfizer indicated for the primary series as a booster dose after the bivalent had been approved.
I developed a rash around my mouth which has not gone away in over 3 weeks now !
fever; headache; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative. The reporter is the parent.  A 12 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "fever"; HEADACHE (non-serious), outcome "unknown", described as "headache". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old male patient received BNT162b2 (BNT162B2), on 13Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High cholesterol" (unspecified if ongoing); "elevated bp" (unspecified if ongoing). Concomitant medication(s) included: SIMVASTATIN, stop date: 07May2022; OLMESARTAN; ASPIRIN 81. Past drug history included: Levaquin, reaction(s): "Known allergies: Levaquinn". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Flu like symptoms; Dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 60 year-old male patient received bnt162b2 (BNT162B2), administration date 12Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "lung problem" (unspecified if ongoing); "multiple sclerosis" (unspecified if ongoing); "asthma" (unspecified if ongoing); "frequent respiratory infections" (unspecified if ongoing); "pulmonology issues" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "Flu like symptoms"; DIZZINESS (non-serious), outcome "unknown", described as "Dizzy".  Additional information; The patient is calling about the Pfizer covid 19 vaccine. The patient and her husband, (name), both got the covid-19 vaccine. The patient had her first dose of the vaccine on 11Mar2021 and her husband had his on 12Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
liver enzymes were higher than usual; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC ENZYME INCREASED (liver enzymes were higher than usual) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced HEPATIC ENZYME INCREASED (liver enzymes were higher than usual). At the time of the report, HEPATIC ENZYME INCREASED (liver enzymes were higher than usual) outcome was unknown.